By Meghan VH
On 09/23/2009
The Consumer Subconscious and Pepto Bismol
While brand name products in the healthcare realm seem to be losing ground to their generic counterparts, Pepto Bismol has added 0.7 market share points in its original formula and 2.5 market share points in stomach remedy tablets despite being priced approximately 60% more than private label products (source: Advertising Age).
While Pepto Bismol brand manager Nathan Fox believes that the recession may have made consumers turn to Pepto Bismol as treatment for multiple symptoms – which is the focus of its advertising campaign “Coverage” (source: Advertising Age) – the brand’s success during the recession could also be due to an unconscious behavioral phenomenon.
Research on the unconscious drivers of behavior has found that consumers will pay more for a brand name drug than a generic...





